Concord Drugs Ltd. (CONCORD)
Market Open
11 Aug, 22:00
MSE MSE Primary ₹
74. 91
+1.09
+1.4766%
₹
313.46M Market Cap
- P/E Ratio
- Div Yield
10,812 Volume
- Eps
₹ 73.82
Previous Close Want to track CONCORD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Concord Drugs Ltd. (CONCORD) Statistics
Valuation metrics
Market Cap 313.46M
Enterprise value 924.01M
Trailing P/E (ttm) 75.76
Forward P/E -
PEG ratio 0.43
Price/Sales (ttm) 1
Price/Book (mrq) 1.65
Enterprise Value/Revenue 1.17
Enterprise Value/EBITDA 20.29
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 10.93K
Average volume (90 days) 5.5K
Price summary
52-Week low 49
52-Week high 92.52
Beta -
50-Day moving average 72.87
200-Day moving average 77.2
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.01%
Operating margin 0.04%
Operational effectiveness
Return on assets 0.01%
Return on equity 0.03%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 70.09
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.94
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.7
Total debt (mrq) -
Total Debt/Equity (mrq) 0.28
Current ratio (mrq) 2.53%
Book value per share (mrq) 43.18
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
